NM

Nazmabanu Mehfuzalam Ansari

Active Director Designated Partner DIN 08508065
DIN 08508065 First appointment Jul 2019 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Nazmabanu Mehfuzalam Ansari

Data last updated:

Nazmabanu Mehfuzalam Ansari is a Designated Partner at Esalun Therapeutics Llp (since 2019). The company operates in Business Services.

DIN 08508065
Primary Designation Designated Partner
Industry Business Services
First Appointment 11 Jul 2019
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner11 Jul 20192019Active

Board colleagues of Nazmabanu Mehfuzalam Ansari

NameDINCompanyDesignation
Irfanali Jamaluddin Shekh08508064Esalun Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Esalun Therapeutics Llp
Premium access

Shareholding and investment profile for Nazmabanu Mehfuzalam Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nazmabanu Mehfuzalam Ansari

Nazmabanu Mehfuzalam Ansari currently holds 1 directorship: Esalun Therapeutics Llp (Designated Partner, since 11 Jul 2019).

Nazmabanu Mehfuzalam Ansari was first appointed on 11 Jul 2019 as Designated Partner at Esalun Therapeutics Llp.

The current boards of Nazmabanu Mehfuzalam Ansari's companies include Irfanali Jamaluddin Shekh (Esalun Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available